HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The nociceptin/orphanin FQ receptor agonist SR-8993 as a candidate therapeutic for alcohol use disorders: validation in rat models.

AbstractRATIONALE:
Alcoholism is a complex disorder in which diverse pathophysiological processes contribute to initiation and progression, resulting in a high degree of heterogeneity among patients. Few pharmacotherapies are presently available, and patient responses to these are variable. The nociceptin/orphanin FQ (NOP) receptor has been suggested to play a role both in alcohol reward and in negatively reinforced alcohol seeking. Previous studies have shown that NOP-receptor activation reduces alcohol intake in genetically selected alcohol-preferring as well as alcohol-dependent rats. NOP activation also blocks stress- and cue-induced reinstatement of alcohol-seeking behavior.
OBJECTIVES:
Here, we aimed to examine a novel, potent, and brain-penetrant small-molecule NOP-receptor agonist, SR-8993, in animal models of alcohol- as well as anxiety-related behavior using male Wistar rats.
RESULTS:
SR-8993 was mildly anxiolytic when given to naïve animals and potently reversed acute alcohol withdrawal-induced ("hangover") anxiety. SR-8993 reduced both home-cage limited access drinking, operant responding for alcohol, and escalation induced through prolonged intermittent access to alcohol. SR-8993 further attenuated stress- as well as cue-induced relapse to alcohol seeking. For the effective dose (1.0 mg/kg), non-specific effects such as sedation may be limited, since a range of control behaviors were unaffected, and this dose did not interact with alcohol elimination.
CONCLUSION:
These findings provide further support for NOP-receptor agonism as a promising candidate treatment for alcoholism and establish SR-8993 or related molecules as suitable for further development as therapeutics.
AuthorsAbdul Maruf Asif Aziz, Shaun Brothers, Gregory Sartor, Lovisa Holm, Markus Heilig, Claes Wahlestedt, Annika Thorsell
JournalPsychopharmacology (Psychopharmacology (Berl)) Vol. 233 Issue 19-20 Pg. 3553-63 (Oct 2016) ISSN: 1432-2072 [Electronic] Germany
PMID27515665 (Publication Type: Journal Article)
Chemical References
  • Central Nervous System Depressants
  • Ligands
  • Receptors, Opioid
  • Ethanol
  • Nociceptin Receptor
  • Oprl protein, rat
Topics
  • Alcoholism
  • Animals
  • Anxiety
  • Behavior, Animal (drug effects)
  • Central Nervous System Depressants (administration & dosage)
  • Conditioning, Operant (drug effects)
  • Drug-Seeking Behavior (drug effects)
  • Ethanol (administration & dosage)
  • Ligands
  • Male
  • Rats
  • Rats, Wistar
  • Receptors, Opioid (agonists)
  • Reinforcement, Psychology
  • Reward
  • Self Administration
  • Substance Withdrawal Syndrome
  • Nociceptin Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: